Key result
DPP4 inhibition mitigated ANG II-mediated kidney injury, characterized by mesangial expansion, mitochondrial damage, and albuminuria, independent of blood pressure reduction in male mice.
Why the study?
Does DPP4 inhibition mitigate ANG II-mediated kidney immune activation and injury in male mice?
Does DPP4 inhibition mitigate ANG II-mediated kidney immune activation and injury in male mice?
DPP4 inhibition mitigates ANG II-induced kidney injury and immune activation in mice, independent of blood pressure changes.
Answers are grounded in this paper and cite their sources.
May mitigate ANG II kidney injury in mice independent of BP; hypothesis-generating, should not change practice.
This work highlights the role of dipeptidyl peptidase-4 (DPP4) in promoting ANG II-mediated kidney inflammation and injury. Specifically, ANG II infusion in mice led to increases in blood pressure and kidney DPP4 activity, which then led to activation of CD8 + T cells, Ly6C − macrophages, and neutrophils and suppression of anti-inflammatory T helper 2 lymphocytes and regulatory T cells. Collectively, this led to kidney injury, characterized by mesangial expansion, mitochondrial damage, and albuminuria, which were mitigated by DPP4 inhibition independent of blood pressure reduction.
No takes yet. Share an insight, caveat, or question.
Nistala et al. (2021) studied ANG II-mediated kidney inflammation and injury. DPP4 inhibition was evaluated on Kidney injury (mesangial expansion, mitochondrial damage, and albuminuria). DPP4 inhibition mitigated ANG II-mediated kidney injury, characterized by mesangial expansion, mitochondrial damage, and albuminuria, independent of blood pressure reduction in male mice.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: